Hoffman Robert E. 4
4 · Kintara Therapeutics, Inc. · Filed Sep 1, 2023
Insider Transaction Report
Form 4
Hoffman Robert E.
Director
Transactions
- Award
Options (Right to Buy)
2023-08-30+23,142→ 23,142 totalExercise: $4.66Exp: 2033-08-30→ Common Stock (23,142 underlying)
Footnotes (1)
- [F1]The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 25% of the options vest on August 30, 2024, with the remaining shares vesting in 36 equal monthly installments commencing on September 30, 2024.